0000950170-24-024222.txt : 20240301 0000950170-24-024222.hdr.sgml : 20240301 20240301195252 ACCESSION NUMBER: 0000950170-24-024222 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240301 FILED AS OF DATE: 20240301 DATE AS OF CHANGE: 20240301 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SMITH WAYNE T CENTRAL INDEX KEY: 0001018660 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15925 FILM NUMBER: 24712427 MAIL ADDRESS: STREET 1: 500 WEST MAIN STREET CITY: LOUISVILLE STATE: KY ZIP: 40202 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: COMMUNITY HEALTH SYSTEMS INC CENTRAL INDEX KEY: 0001108109 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 133893191 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4000 MERIDIAN BOULEVARD CITY: FRANKLIN STATE: TN ZIP: 37067 BUSINESS PHONE: 615-465-7000 MAIL ADDRESS: STREET 1: 4000 MERIDIAN BOULEVARD CITY: FRANKLIN STATE: TN ZIP: 37067 FORMER COMPANY: FORMER CONFORMED NAME: COMMUNITY HEALTH SYSTEMS INC/ DATE OF NAME CHANGE: 20000229 4 1 ownership.xml 4 X0508 4 2024-03-01 0001108109 COMMUNITY HEALTH SYSTEMS INC CYH 0001018660 SMITH WAYNE T 4000 MERIDIAN BOULEVARD FRANKLIN TN 37067 true false false false false Common Stock 2024-03-01 4 M false 144000 0 A 5227075 D Common Stock 1606842 I by The Modified 2009 WTS Irrev Trust Dated 12/16/22 Common Stock 481721 I WAC LLC Performance Based Restricted 0 2024-03-01 4 M false 144000 0 D Common Stock 144000 36000 D Performance Based Restricted 0 2024-03-01 4 D false 36000 0 D Common Stock 36000 0 D Restricted Stock Units 0 2024-03-01 4 A false 62718 2.87 A Common Stock 62718 62718 D Restricted Stock Units 0 2024-03-01 4 A false 92334 2.87 A Common Stock 92334 92334 D Performance Based Restricted 0 Common Stock 180000 180000 D Restricted Stock Units 0 Common Stock 29268 29268 D Restricted Stock Units 0 Common Stock 43089 43089 D Stock Options (Right to Buy) 4.99 2020-03-01 2029-02-28 Common Stock 78750 78750 D Stock Options (Right to Buy) 4.93 2021-03-01 2030-02-28 Common Stock 112500 112500 D Stock Options (Right to Buy) 8.81 2022-03-01 2031-02-28 Common Stock 90000 90000 D Stock Options (Right to Buy) 10.18 2023-03-01 2032-02-29 Common Stock 90000 90000 D Stock Units (SU) 0 Common Stock 35609.301 35609.301 D The vesting of these 180,000 performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2021 and 12/31/2023 (the "2021-2023 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2021-2023 Performance Period, the award vested on March 1, 2024 at 80% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2021 (144,000), and the remaining 20% of the target number has been forfeited (36,000). The restricted stock units vest in 1/3 increments on the first, second and third anniversary of the date of grant. Based on the Reporting Person's prior deferral election pursuant to the terms of the award agreement, the Reporting Person will be issued that number of shares of common stock of the Company upon the Reporting Person's cessation as a director or upon a date specified by the Reporting Person. The restricted stock units, which were granted as payment of the Reporting Person's additional annual stipend for serving as the Chair of the Board, vest in 1/3 increments on the first, second and third anniversary of the date of grant. Based on the Reporting Person's prior deferral election pursuant to the terms of the award agreement, the Reporting Person will be issued that number of shares of common stock of the Company upon the Reporting Person's cessation as a director or upon a date specified by the Reporting Person. The vesting of these performance-based restricted shares is subject to the attainment of certain performance objectives between 1/1/2022 and 12/31/2024 (the "2022-2024 Performance Period"). The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each applicable performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2022-2024 Performance Period. Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant. The Stock Units were accrued under the Company's Directors' Fees Deferral Plan in lieu of a portion of the Reporting Person's Director Fees and are settled 100% in the Company's common stock on the last business day of the calendar quarter following cessation as a director or upon a date specified by the Reporting Person. Christopher G. Cobb, Attorney in Fact for Wayne T. Smith 2024-03-01